Globally, 2019 will be a year of value-based care as we expect the ‘outcomes-based care’ focus to globalize. This will trigger maturation of risk-sharing in solution contracting between providers and drug/device original equipment manufacturers (OEMs), driving business value for providers. Furthermore, access to affordable and quality care will be key political agendas for upcoming 2019 elections in emerging markets such as Asia, Africa and, Central and Eastern European countries.